Document is current
Any future updates will be listed below
-
Authors
Stauffer, Eva-Maria https://orcid.org/0000-0003-2904-5555
Bethlehem, Richard A. I. https://orcid.org/0000-0002-0714-0685
Dorfschmidt, Lena https://orcid.org/0000-0002-0447-1104
Won, Hyejung https://orcid.org/0000-0003-3651-0566
Warrier, Varun https://orcid.org/0000-0003-4532-8571
Bullmore, Edward T.
- License Information
-
More Information
Article History
Received: 6 April 2023
Accepted: 14 November 2023
First Online: 28 November 2023
Competing interests
: E.T.B. has consulted for GlaxoSmithKline, SR One, Boehringer Ingelheim, Sosei Heptares, and Monument Therapeutics. R.A.I.B. and E.T.B. are directors of and hold stock in CentileBio. All other authors declare no conflicts of interest.
